These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20462847)

  • 41. [Drug therapy of Crohn disease].
    Niemelä S
    Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
    [No Abstract]   [Full Text] [Related]  

  • 42. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.
    Peyrin-Biroulet L; Deltenre P; Ardizzone S; D'Haens G; Hanauer SB; Herfarth H; Lémann M; Colombel JF
    Am J Gastroenterol; 2009 Aug; 104(8):2089-96. PubMed ID: 19568226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts.
    Peyrin-Biroulet L; Oussalah A; Roblin X; Sparrow MP
    Aliment Pharmacol Ther; 2011 Mar; 33(6):707-13. PubMed ID: 21251032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease.
    Klein O; Colombel JF; Lescut D; Gambiez L; Desreumaux P; Quandalle P; Cortot A
    Am J Gastroenterol; 1995 Nov; 90(11):1949-52. PubMed ID: 7484997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade.
    Schwartz M; Regueiro M
    Curr Gastroenterol Rep; 2011 Feb; 13(1):95-100. PubMed ID: 21042888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.
    Doherty GA; Miksad RA; Cheifetz AS; Moss AC
    Inflamm Bowel Dis; 2012 Sep; 18(9):1608-16. PubMed ID: 21905173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial.
    McLeod RS; Wolff BG; Ross S; Parkes R; McKenzie M;
    Dis Colon Rectum; 2009 May; 52(5):919-27. PubMed ID: 19502857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesalazine for the treatment of inflammatory bowel disease.
    Criscuoli V; Modesto I; Orlando A; Cottone M
    Expert Opin Pharmacother; 2013 Aug; 14(12):1669-78. PubMed ID: 23767798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Medical therapy of inflammatory bowel diseases: Crohn's disease].
    Lakatos L; Lakatos PL
    Orv Hetil; 2007 Jun; 148(24):1107-14. PubMed ID: 17561480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
    Hayee BH; Harris AW
    Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
    [No Abstract]   [Full Text] [Related]  

  • 54. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
    Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
    Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Follow up of Crohn's disease under therapy with hydro-MRI].
    Ganten M; Encke J; Flosdorff P; Grüber-Hoffmann B; Erb G; Hansmann J
    Radiologe; 2003 Jan; 43(1):26-33. PubMed ID: 12552372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infliximab versus azathioprine to prevent postoperative recurrence in Crohn's disease: are all controversial issues defined?
    Kotze PG; Yamamoto T
    J Crohns Colitis; 2013 Dec; 7(12):e698. PubMed ID: 23932785
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of immunosuppressives in special situations: perianal disease and postoperative period.
    Ghosh S; Iacucci M
    Dig Dis; 2014; 32 Suppl 1():92-5. PubMed ID: 25531359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Colombel JF; Lémann M; Cassagnou M; Bouhnik Y; Duclos B; Dupas JL; Notteghem B; Mary JY
    Am J Gastroenterol; 1999 Mar; 94(3):674-8. PubMed ID: 10086650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapy of Crohn disease in internal medicine: postoperative recurrence and fistulas].
    Volk-Zeiher BA; Blum HE
    Praxis (Bern 1994); 1998 Nov; 87(48):1657-60. PubMed ID: 9881040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New research results give hope. Causal therapy of Crohn disease in sight].
    MMW Fortschr Med; 2004 Apr; 146(14):42-3. PubMed ID: 15344754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.